Next report date
Report period
Q1 2024
EPS estimate
−0.48USD
Revenue estimate
1.66 MUSD
−160.93 MUSD
63.53 MUSD
99.49 M
Om Fate Therapeutics, Inc.
Sektor
Bransch
VD
J. Scott Wolchko
Webbplats
Huvudkvarter
San Diego
Employees (FY)
181
Grundat
2007
FIGI
BBG000QP35H2
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
